Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model

American Journal of Hematology

Volumn 86, Issue 2, 2011, Pages 155-162

  Awandare, Gordon A ^a,b   Kempaiah, Prakasha ^c   Ochiel, Daniel O ^a   Piazza, Paolo ^a   Keller, Christopher C ^a,d   Perkins, Douglas J ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF GHANA   (Ghana)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; GLYCOPHORIN A; HEMOZOIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DYSERYTHROPOIESIS; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MALARIA FALCIPARUM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANEMIA; ANTIGENS, CD34; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; GLYCOPHORIN; HEMATOPOIETIC STEM CELLS; HEMEPROTEINS; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALARIA; MALARIA, FALCIPARUM; NITRIC OXIDE; NITRIC OXIDE DONORS; PIGMENTS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78851470600     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21933     Document Type: Article

References (44)

1. World Health Organization. World Malaria Report 2010. WHO Press. Geneva, Switzerland. Available at:
2. Were T, Hittner JB, Ouma C, et al. Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica 2006; 91: 1396-1399.
3. Keller CC, Ouma C, Ouma Y, Awandare GA, et al. Suppression of a novel hematopoietic mediator in children with severe malarial anemia. Infect Immun 2009; 77: 3864-3871.
4. Burchard GD, Radloff P, Philipps J, et al. Increased erythropoietin production in children with severe malarial anemia. Am J Trop Med Hyg 1995; 53: 547-551.
5. Burgmann H, Looareesuwan S, Kapiotis S, et al. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg 1996; 54: 280-283.
6. Kurtzhals JA, Rodrigues O, Addae M, et al. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997; 97: 169-174.
7. Nussenblatt V, Mukasa G, Metzger A, et al. Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol 2001; 8: 1164-70.
8. Casals-Pascual C, Kai O, Cheung JO, et al. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 2006; 108: 2569-2577.
9. Awandare GA, Ouma Y, Ouma C, et al. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun 2007; 75: 201-210.
10. Wickramasinghe SN, Abdalla SH. Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 2000; 13: 277-299.
11. Chang KH, Stevenson MM. Malarial anaemia: Mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int J Parasitol 2004; 34: 1501-1516.
12. Nguyen PH, Day N, Pram TD, et al. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 1995; 89: 200-204.
13. Luty AJ, Perkins DJ, Lell B, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68: 3909-3915.
14. Perkins DJ, Weinberg JB, Kremsner PG. Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J Infect Dis 2000; 182: 988-992.
15. Lyke KE, Diallo DA, Dicko A, et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg 2003; 69: 253-259.
16. Perkins DJ, Moore JM, Otieno J, et al. In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-alpha, and IL-10. Biochem Biophys Res Commun 2003; 311: 839-846.
17. Keller CC, Kremsner PG, Hittner JB, et al. Elevated nitric oxide production in children with malarial anemia: Hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun 2004; 72: 4868-4873.
18. Keller CC, Yamo O, Ouma C, et al. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: In vivo and in vitro findings in severe malarial anemia. Infect Immun 2006; 74: 5249-5260.
19. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 1988; 70: 99-103.
20. Kwiatkowski D, Cannon JG, Manogue KR, et al. Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989; 77: 361-366.
21. Kwiatkowski D, Hill AV, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990; 336: 1201-1204.
22. Anstey NM, Granger DL, Hassanali M, et al. Nitric oxide, malaria, and anemia: Inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children. Am J Trop Med Hyg 1999; 61: 249-252.
23. Jaramillo M, Godbout M, Olivier M. Hemozoin induces macrophage chemokine expression through oxidative stress-dependent and-independent mechanisms. J Immunol 2005; 174: 475-484.
24. Akman-Anderson L, Olivier M, Luckhart S. Induction of nitric oxide synthase and activation of signaling proteins in Anopheles mosquitoes by the malaria pigment, hemozoin. Infect Immun 2007; 75: 4012-4019.
25. Awandare GA, Hittner JB, Kremsner PG, et al. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Clin Immunol 2006; 119: 219-225.
26. Awandare GA, Goka B, Boeuf P, et al. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J Infect Dis 2006; 194: 1438-1446.
27. Freyssinier JM, Lecoq-Lafon C, Amsellem S, et al. Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol 1999; 106: 912-922.
28. Neildez-Nguyen TM, Wajcman H, Marden MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002; 20: 467-472.
29. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976; 193: 673-675.
30. Keller CC, Hittner JB, Nti BK, et al. Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism. Mol Med 2004; 10: 45-54.
31. Xiao W, Koizumi K, Nishio M, et al. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells. Exp Hematol 2002; 30: 1238-1247.
32. Ouma C, Keller CC, Opondo DA, et al. Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. Am J Trop Med Hyg 2006; 74: 573-577.
33. Ong'echa JM, Remo AM, Kristoff J, et al. Increased circulating interleukin (IL)-23 in children with malarial anemia: In vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10. Clin Immunol 2008; 126: 211-221.
34. Ouma C, Davenport GC, Awandare GA, et al. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. J Infect Dis 2008; 198: 1219-1226.
35. Schwarzer E, Ludwig P, Valente E, Arese P. 15(S)-hydroxyeicosatetraenoic acid (15-HETE), a product of arachidonic acid peroxidation, is an active component of hemozoin toxicity to monocytes. Parassitologia 1999; 41: 199-202.
36. Schwarzer E, Kuhn H, Valente E, Arese P. Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions. Blood 2003; 101: 722-728.
37. Ochiel DO, Awandare GA, Keller CC, et al. Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. Infect Immun 2005; 73: 4190-4197.
38. Schwarzer E, Skorokhod OA, Barrera V, Arese P. Hemozoin and the human monocyte-A brief review of their interactions. Parassitologia 2008; 50: 143-145.
39. Lamikanra AA, Theron M, Kooij TW, Roberts DJ. Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS One 2009; 4: e8446.
40. Giribaldi G, Ulliers D, Schwarzer E, et al. Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia. Haematologica 2004; 89: 492-493.
41. Johnson RA, Waddelow TA, Caro J, et al. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 1989; 74: 130-138.
42. Shami PJ, Weinberg JB. Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells. Blood 1996; 87: 977-982.
43. Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: Role of p55 and p75 TNF receptors. Blood 1995; 85: 989-996.
44. Cokic VP, Schechter AN. Effects of nitric oxide on red blood cell development and phenotype. Curr Top Dev Biol 2008; 82: 169-215.